Effects of phenylbutazone on gene expression of cyclooxygenase-1 and -2 in the oral, glandular gastric, and bladder mucosae of healthy horses
Authors:
- Jorge E. NietoJNJorge E. Nieto
- Monica AlemanMAMonica Aleman
- Jonathan D. AndersonJAJonathan D. Anderson
- Ciara FiackCFCiara Fiack
- Jack R. SnyderJSJack R. Snyder
- 1 January 2012
- journal article
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 73 (1) , 98-104
Abstract
Objective—To assess gene expressions of cyclooxygenase-1 and -2 in oral, glandular gastric, and urinary bladder mucosae and determine the effect of oral administration of phenylbutazone on those gene expressions in horses. Animals—12 healthy horses. Procedures—Horses were allocated to receive phenylbutazone or placebo (6 horses/group); 1 placebo-treated horse with a cystic calculus was subsequently removed from the study, and those data were not analyzed. In each horse, the stomach and urinary bladder were evaluated for ulceration via endoscopy before and after experimental treatment. Oral, glandular gastric, and urinary bladder mucosa biopsy specimens were collected by use of a skin punch biopsy instrument (oral) or transendoscopically (stomach and bladder) before and after administration of phenylbutazone (4.4 mg/kg, PO, q 12 h) in corn syrup or placebo (corn syrup alone) for 7 days. Cyclooxygenase-1 and -2 gene expressions were determined (via quantitative PCR techniques) in specimens collected before and after the 7-day treatment period and compared within and between groups. Prior to commencement of treatment, biopsy specimens from 7 horses were used to compare gene expressions among tissues. Results—The cyclooxygenase-1 gene was expressed in all tissues collected. The cyclooxygenase-2 gene was expressed in the glandular gastric and bladder mucosae but not in the oral mucosa. Cyclooxygenase gene expressions were unaffected by phenylbutazone administration. Conclusions and Clinical Relevance—Cyclooxygenase-2 was constitutively expressed in glandular gastric and bladder mucosae but not in the oral mucosa of healthy horses. Oral administration of phenylbutazone at the maximum recommended dosage daily for 7 days did not affect cyclooxygenase-1 or -2 gene expression.Keywords
This publication has 25 references indexed in Scilit:
- Ulcerative cystitis associated with phenylbutazone administration in two horsesJournal of the American Veterinary Medical Association, 2011
- Gene expression of proteolytic systems and growth regulators of skeletal muscle in horses with myopathy associated with pituitary pars intermedia dysfunctionAmerican Journal of Veterinary Research, 2010
- Structural and Functional Basis of Cyclooxygenase InhibitionJournal of Medicinal Chemistry, 2007
- Effects of phenylbutazone alone or in combination with flunixin meglumine on blood protein concentrations in horsesAmerican Journal of Veterinary Research, 2006
- Medical treatment of osteoarthritis in the horse – A reviewThe Veterinary Journal, 2006
- Update on cyclooxygenase inhibitors: has a third COX isoform entered the fray?Current Medical Research and Opinion, 2005
- Cyclooxygenases: Structural, Cellular, and Molecular BiologyAnnual Review of Biochemistry, 2000
- Renal Papillary Necrosis in Horses after Phenylbutazone and Water DeprivationVeterinary Pathology, 1983
- Phenylbutazone toxicity in ponies1979
- Phenylbutazone toxicity in poniesVeterinary Record, 1979